Real-world data on adjuvant capecitabine after standard neoadjuvant chemotherapy for triple negative breast cancer.

Rev Bras Ginecol Obstet · 2024 · PMC11341194 · PMID 39176205

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

A recent report demonstrated a clear trend in favor of NACT over AC for all early-stage breast cancer subtypes in Germany.

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.